Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust

Reuters02-07

Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust

Healthlynked Corporation has announced the issuance and sale of a Senior Secured Convertible Promissory Note valued at $5,715,811.98 to the Mary S. Dent Gifting Trust, an entity controlled by the company’s Chief Executive Officer and Chairman, Dr. Michael Dent. The transaction was completed as a private placement, relying on exemptions from SEC registration under Section 4(a)(2) of the Securities Act and Regulation D. The note, which matures on February 2, 2029, accrues interest at 12% per annum and is secured by a first priority lien on all company assets. It is convertible into Healthlynked common stock at $4.25 per share at the purchaser’s option prior to maturity. The proceeds were used to cancel outstanding promissory notes, advances, and unpaid compensation owed to Dr. Dent.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthlynked Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013261), on February 06, 2026, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2609511821?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-07 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609511821","market":"us","top_or_hot":-1,"title":"Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Healthlynked Corporation has announced the issuance and sale of a Senior Secured Convertible Promissory Note valued at $5,715,811.98 to the Mary S. Dent Gifting Trust, an entity controlled by the company’s Chief Executive Officer and Chairman, Dr. Michael Dent. The transaction was completed as a private placement, relying on exemptions from SEC registration under Section 4(a)(2) of the Securities Act and Regulation D. The note, which matures on February 2, 2029, accrues interest at 12% per annum and is secured by a first priority lien on all company assets. It is convertible into Healthlynked common stock at $4.25 per share at the purchaser’s option prior to maturity. The proceeds were used to cancel outstanding promissory notes, advances, and unpaid compensation owed to Dr. Dent.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthlynked Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013261), on February 06, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-02-07 05:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Healthlynked Corporation has announced the issuance and sale of a Senior Secured Convertible Promissory Note valued at $5,715,811.98 to the Mary S. Dent Gifting Trust, an entity controlled by the company’s Chief Executive Officer and Chairman, Dr. Michael Dent. The transaction was completed as a private placement, relying on exemptions from SEC registration under Section 4(a)(2) of the Securities Act and Regulation D. The note, which matures on February 2, 2029, accrues interest at 12% per annum and is secured by a first priority lien on all company assets. It is convertible into Healthlynked common stock at $4.25 per share at the purchaser’s option prior to maturity. The proceeds were used to cancel outstanding promissory notes, advances, and unpaid compensation owed to Dr. Dent.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthlynked Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013261), on February 06, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4167","symbol_name":"医疗保健技术","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL99bph6:1","article_id":"2609511821","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609511821","pubTimestamp":1770411690,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Healthlynked Corporation has announced the issuance and sale of a Senior Secured Convertible Promissory Note valued at $5,715,811.98 to the Mary S. Dent Gifting Trust, an entity controlled by the company’s Chief Executive Officer and Chairman, Dr. Michael Dent. The transaction was completed as a private placement, relying on exemptions from SEC registration under Section 4 of the Securities Act and Regulation D. The note, which matures on February 2, 2029, accrues interest at 12% per annum and is secured by a first priority lien on all company assets. It is convertible into Healthlynked common stock at $4.25 per share at the purchaser’s option prior to maturity. The proceeds were used to cancel outstanding promissory notes, advances, and unpaid compensation owed to Dr. Dent.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4167":"医疗保健技术","HLYK":"HealthLynked Corp."},"translate_title":"Healthlynked向首席执行官控制的信托公司发行570万美元可转换票据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HLYK":0.9},"content_text":"Healthlynked Issues $5.7 Million Convertible Note to CEO-Controlled Trust\n    \n\n        Healthlynked Corporation has announced the issuance and sale of a Senior Secured Convertible Promissory Note valued at $5,715,811.98 to the Mary S. Dent Gifting Trust, an entity controlled by the company’s Chief Executive Officer and Chairman, Dr. Michael Dent. The transaction was completed as a private placement, relying on exemptions from SEC registration under Section 4(a)(2) of the Securities Act and Regulation D. The note, which matures on February 2, 2029, accrues interest at 12% per annum and is secured by a first priority lien on all company assets. It is convertible into Healthlynked common stock at $4.25 per share at the purchaser’s option prior to maturity. The proceeds were used to cancel outstanding promissory notes, advances, and unpaid compensation owed to Dr. Dent.\n      \n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Healthlynked Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-013261), on February 06, 2026, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609511821","isCrawlerRequest":true}